1. Home
  2. VNDA vs FRGE Comparison

VNDA vs FRGE Comparison

Compare VNDA & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • FRGE
  • Stock Information
  • Founded
  • VNDA N/A
  • FRGE 2014
  • Country
  • VNDA United States
  • FRGE United States
  • Employees
  • VNDA N/A
  • FRGE N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • FRGE Computer Software: Prepackaged Software
  • Sector
  • VNDA Health Care
  • FRGE Technology
  • Exchange
  • VNDA Nasdaq
  • FRGE Nasdaq
  • Market Cap
  • VNDA 362.6M
  • FRGE 302.3M
  • IPO Year
  • VNDA 2006
  • FRGE N/A
  • Fundamental
  • Price
  • VNDA $6.07
  • FRGE $1.49
  • Analyst Decision
  • VNDA Buy
  • FRGE Buy
  • Analyst Count
  • VNDA 1
  • FRGE 2
  • Target Price
  • VNDA $11.00
  • FRGE $5.25
  • AVG Volume (30 Days)
  • VNDA 955.3K
  • FRGE 415.7K
  • Earning Date
  • VNDA 07-29-2024
  • FRGE 08-06-2024
  • Dividend Yield
  • VNDA N/A
  • FRGE N/A
  • EPS Growth
  • VNDA N/A
  • FRGE N/A
  • EPS
  • VNDA N/A
  • FRGE N/A
  • Revenue
  • VNDA $177,604,000.00
  • FRGE $73,584,000.00
  • Revenue This Year
  • VNDA $2.98
  • FRGE $27.87
  • Revenue Next Year
  • VNDA $19.49
  • FRGE $36.74
  • P/E Ratio
  • VNDA N/A
  • FRGE N/A
  • Revenue Growth
  • VNDA N/A
  • FRGE 13.49
  • 52 Week Low
  • VNDA $3.30
  • FRGE $1.31
  • 52 Week High
  • VNDA $6.75
  • FRGE $4.02
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 57.74
  • FRGE 48.95
  • Support Level
  • VNDA $5.75
  • FRGE $1.36
  • Resistance Level
  • VNDA $5.39
  • FRGE $1.50
  • Average True Range (ATR)
  • VNDA 0.27
  • FRGE 0.08
  • MACD
  • VNDA 0.05
  • FRGE 0.03
  • Stochastic Oscillator
  • VNDA 78.99
  • FRGE 48.38

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About FRGE Forge Global Holdings Inc.

Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The Company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.

Share on Social Networks: